Why the study?
Depot-specific adipose traits outperform BMI in predicting disease risk, necessitating a multiscale framework translating adipose heterogeneity into precision risk management and targeted therapies.
Design
Review
Authors
Loading...
Depot-specific adipose traits may refine CV risk prediction beyond BMI; leaves open prospective validation of targeted therapies.
Key points are not available for this paper at this time.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: